{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:25:59Z","timestamp":1768260359699,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.yebeh.2021.107840","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T16:42:27Z","timestamp":1613925747000},"page":"107840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Influence of titration of antiseizure medications on treatment selection: Results of an online survey with clinicians in the United States"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9739-6598","authenticated-orcid":false,"given":"Betsy","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry E.","family":"Gidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1945-8797","authenticated-orcid":false,"given":"John","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Sparling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-8931","authenticated-orcid":false,"given":"Joshua","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8002-6838","authenticated-orcid":false,"given":"Craig","family":"Plauschinat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.107840_b0005","unstructured":"World Health Organization. Epilepsy, Key facts. 2019; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/epilepsy."},{"issue":"6","key":"10.1016\/j.yebeh.2021.107840_b0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2021.107840_b0015","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1528-1167.2006.00595.x","article-title":"Epilepsy Care in the World: results of an ILAE\/IBE\/WHO Global Campaign Against Epilepsy survey","volume":"47","author":"Dua","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2021.107840_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nrl.2012.04.012","article-title":"Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study","volume":"28","author":"Villanueva","year":"2013","journal-title":"Neurologia"},{"issue":"5","key":"10.1016\/j.yebeh.2021.107840_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.seizure.2014.01.016","article-title":"Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study)","volume":"23","author":"de Z\u00e9licourt","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2021.107840_b0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yebeh.2015.12.018","article-title":"Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: an analysis from the National Health and Wellness Survey","volume":"55","author":"Gupta","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2021.107840_b0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/jamaneurol.2017.3069","article-title":"Questioning the effectiveness of newer antiseizure medications","volume":"75","author":"Hauser","year":"2018","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.yebeh.2021.107840_b0040","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/epi.14557","article-title":"Progress report on new antiepileptic drugs: a summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development","volume":"59","author":"Bialer","year":"2018","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2021.107840_b0045","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1684\/epd.2016.0836","article-title":"Treatment of epilepsy in adults","volume":"18","author":"Burakgazi","year":"2016","journal-title":"Epileptic Disord"},{"issue":"2","key":"10.1016\/j.yebeh.2021.107840_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.0000000000005756","volume":"91","author":"Kanner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.107840_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107840_b0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3389\/fneur.2017.00712","article-title":"The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using German health insurance data","volume":"8","author":"Strzelczyk","year":"2017","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107840_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yebeh.2010.06.002","article-title":"European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice","volume":"19","author":"Ross","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.107840_b0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2017.01.032","article-title":"Patient emotions and perceptions of antiepileptic drug changes and titration during treatment for epilepsy","volume":"69","author":"Fishman","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"9","key":"10.1016\/j.yebeh.2021.107840_b0075","first-page":"929","article-title":"Antiepileptic drug titration and related health care resource use and costs","volume":"24","author":"Fishman","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.yebeh.2021.107840_b0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.107840_b0085","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/18-129","article-title":"Acute convulsive seizures: when is it too early to treat?","volume":"23","author":"Hussein","year":"2019","journal-title":"Perm J"},{"issue":"6","key":"10.1016\/j.yebeh.2021.107840_b0090","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and epilepsy: an overview for neuroscientists","volume":"5","author":"Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"10.1016\/j.yebeh.2021.107840_b0095","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.seizure.2010.05.008","article-title":"Antiepileptic treatment in patients with epilepsy and other comorbidities","volume":"19","author":"Ruiz-Gim\u00e9nez","year":"2010","journal-title":"Seizure"},{"issue":"37","key":"10.1016\/j.yebeh.2021.107840_b0100","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.2174\/1381612823666170926103631","article-title":"Specific patient features affect antiepileptic drug therapy decisions: focus on gender, age, and psychiatric comorbidities","volume":"23","author":"Pisani","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.yebeh.2021.107840_b0105","doi-asserted-by":"crossref","unstructured":"Sveinsson O, Andersson T, Mattsson P, Carlsson S, Tomson T. Clinical risk factors in SUDEP. A nationwide population-based case-control study, 2020. 94(4): p. e419-e429.","DOI":"10.1212\/WNL.0000000000008741"},{"issue":"12","key":"10.1016\/j.yebeh.2021.107840_b0110","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11910-014-0502-4","article-title":"Sudden unexpected death in epilepsy: addressing the challenges","volume":"14","author":"Smithson","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"10.1016\/j.yebeh.2021.107840_b0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/epi.12666","article-title":"Sudden unexpected death in epilepsy: assessing the public health burden","volume":"55","author":"Thurman","year":"2014","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107840_b0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1535-7597.2001.00012.x","article-title":"Sudden unexplained death in epilepsy","volume":"1","author":"Sperling","year":"2001","journal-title":"Epilepsy Curr"},{"issue":"6","key":"10.1016\/j.yebeh.2021.107840_b0125","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3889\/oamjms.2018.235","article-title":"How to improve clinical outcome of epileptic seizure control based on medication adherence? A literature review","volume":"6","author":"Ernawati","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"issue":"3","key":"10.1016\/j.yebeh.2021.107840_b0130","first-page":"314","article-title":"Epilepsy","volume":"2","author":"Conway","year":"2019","journal-title":"JACCP"},{"issue":"6","key":"10.1016\/j.yebeh.2021.107840_b0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/NRL.0000000000000140","article-title":"Burden of seizure clusters on patients with epilepsy and caregivers: survey of patient, caregiver, and clinician perspectives","volume":"22","author":"Penovich","year":"2017","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.yebeh.2021.107840_b0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0145721712467696","article-title":"Barriers to insulin progression among patients with type 2 diabetes: a systematic review","volume":"39","author":"Polinski","year":"2013","journal-title":"Diabetes Educ"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:36:07Z","timestamp":1761503767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":28,"alternative-id":["S1525505021000743"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107840","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of titration of antiseizure medications on treatment selection: Results of an online survey with clinicians in the United States","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.107840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107840"}}